Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap31.50K
Market cap31.50K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today$0.0008
High today$0.0008
Low today$0.0005
Low today$0.0005
Open price$0.0008
Open price$0.0008
Volume13.86K
Volume13.86K
52 Week high$5.22
52 Week high$5.22
52 Week low$0.0005
52 Week low$0.0005
Stock Snapshot
Syros Pharmaceuticals(SYRS) stock is priced at $0.00, giving the company a market capitalization of 31.5K.
As of 2025-12-17, Syros Pharmaceuticals(SYRS) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock 0.0% above today's low and -37.5% off the high.
Syros Pharmaceuticals(SYRS) shares are trading with a volume of 13.86K, against a daily average of 5.31M.
In the last year, Syros Pharmaceuticals(SYRS) shares hit a 52-week high of $5.22 and a 52-week low of $0.00.
In the last year, Syros Pharmaceuticals(SYRS) shares hit a 52-week high of $5.22 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.